Form 4: Health Catalyst CCO Sells Shares for Tax Obligations

Health Catalyst's Chief Commercial Officer, Kevin Lee Freeman, disposed of 4,578 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Kevin Lee Freeman, Chief Commercial Officer of Health Catalyst, Inc., disposed of 4,578 shares of common stock.
• The transaction occurred on September 2, 2025, at a price of $3.3627 per share.
• This disposition was a "sell to cover" transaction, mandated by the company's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The sale was not a discretionary trade by Mr. Freeman.
• Following this transaction, Mr. Freeman beneficially owns 375,087 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' to satisfy tax obligations related to RSU vesting, which is a neutral event and does not reflect a change in management's outlook or a discretionary sale.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal impact on shareholders as it is a routine, non-discretionary transaction for tax purposes and represents a small percentage of the company's outstanding shares and the insider's total holdings.

Key Dates

Keywords

Health Catalyst, HCAT, Kevin Lee Freeman, Chief Commercial Officer, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Sell to Cover